/Companies

Scioto Biosciences

Indianopolis, US · Founded 2017 · 7 known investors

Find your way into Scioto Biosciences

Sign up to see every warm intro you have to Scioto Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Scioto Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Scioto Biosciences is a life sciences company with corporate offices and research facilities in Fishers, Indiana. This page describes its office locations and employee benefits rather than detailing its products.

Founders & leadership

Scioto Biosciences was founded in 2017 by Joe Trebley and Jim Schulz.

JTJoe Trebley
Joe TrebleyFounder & Chief Executive Officer
JSJim Schulz
Jim SchulzFounder & Chief Financial OfficerHe has prior experience in the biotechnology industry and expertise in business planning, medical devices, and mergers & acquisitions.
MHMark Heiman
Mark HeimanCSODr. Heiman earned a Ph.D. in Physiology from LSU School of Medicine and completed postdoctoral training in neuroendocrinology at Indiana University School of Medicine. He co-invented the drug Lanreotide while at Tulane University School of Medicine, subsequently led metabolic physiology research at Eli Lilly for over two decades including discoveries in leptin and ghrelin regulation, and later served as Chief Scientific Officer of MicroBiome Therapeutics before joining Scioto Biosciences.
KM
Kevin MeyerChief Operating Officer

Investors · 7

Also in the syndicate · 1

Genome & Companylead

Funding

SEC filings, press & company announcements

$1.8M disclosed across 1 of 2 rounds · 2018–2020

  • Undisclosed amountSeries BAug 2020

    Genome & Company (lead)

    Source ↗
▶$1.8MraisedMay 2018 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark HeimanExecutive Officer
  • Joseph TrebleyExecutive Officer, Director
  • James SchulzExecutive Officer, Director
  • Kevin MeyerExecutive Officer
Offering amount
$4M
Amount sold
$1.8M
First sale
Apr 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$2.3M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

What does Scioto Biosciences do?
Scioto Biosciences is a life sciences company with corporate offices and research facilities in Fishers, Indiana. This page describes its office locations and employee benefits rather than detailing its products.
Who founded Scioto Biosciences?
Scioto Biosciences was founded by Joe Trebley, Jim Schulz in 2017.
Who are Scioto Biosciences's investors?
Scioto Biosciences's investors include Elevate Ventures, IU Ventures, Michigan Capital Network, Pathway Bioventures, BioCrossroads, Rev1 Ventures.
How much funding has Scioto Biosciences raised?
Scioto Biosciences has disclosed $1.8M raised across 1 of its 2 known rounds.
Where is Scioto Biosciences headquartered?
Scioto Biosciences is headquartered in Indianopolis, US.